
This answer needs verification — Pennsylvania CRNP prescribing authority for codeine cannot be summarized as a publishable yes/no answer until Schedule V authority is reconciled. Codeine’s DEA schedule varies by formulation and dosage, so a given codeine product may be treated differently under Pennsylvania controlled-substance schedules.3
Pennsylvania authority is clear for CRNP prescriptions for Schedule II drugs up to a 30-day supply, and Schedule III or IV drugs up to a 90-day supply, when that authority is identified in the physician collaborative agreement.1 But the project source matrix flags Pennsylvania Schedule V CRNP authority for final verification, which matters for codeine formulations that may not fall within the clear Schedule II–IV rules.2
Before this FAQ is published, confirm the applicable codeine formulation and Pennsylvania Schedule V CRNP authority; any controlled-substance prescription would also require current Pennsylvania CRNP prescriptive authority approval, prescribing within the CRNP's specialty, and DEA registration. Pennsylvania PDMP duties may also apply because PDMP guidance requires a query each time an opioid drug product is prescribed.4